Literature DB >> 11758818

Drug offenders in Taiwan and the United States: a cross-cultural analysis.

F Deng1, M S Vaughn, L J Lee.   

Abstract

Using data collected from nationwide surveys of drug-using offenders in the United States and Taiwan, this article compares offender differences with respect to socio-demographic characteristics, childhood experiences, drug use and treatment patterns, and criminal histories. The results suggest that the experiences of U.S. drug-using offenders are more complex, with multiple routes and consequences of drug use, while the social constructionist view is more appropriate to explain the experience of Taiwanese drug-using offenders. Overall, U.S. drug-using offenders reported earlier drug and criminal involvement, experienced more prior arrests, and committed more non-drug-related crimes. Family problems were more prevalent among U.S. drug-using offenders than Taiwanese drug-using offenders. Drug-using offenders in the U.S. also reported using a variety of different drugs and participating in multiple treatment programs. The major agents supplying illicit drugs were known dealers, and friends or acquaintances of U.S. and Taiwanese drug-using offenders, respectively. The article concludes that to effectively eliminate the problem of drug misuse, the Taiwanese government should focus on treatment instead of imprisonment, while the U.S. should target troubled teens and families.

Mesh:

Substances:

Year:  2001        PMID: 11758818     DOI: 10.1081/ja-100107574

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  2 in total

Review 1.  A structured review of reasons for ecstasy use and related behaviours: pointers for future research.

Authors:  Gjalt-Jorn Ygram Peters; Gerjo Kok
Journal:  BMC Public Health       Date:  2009-07-13       Impact factor: 3.295

Review 2.  Social cognitive determinants of ecstasy use to target in evidence-based interventions: a meta-analytical review.

Authors:  Gjalt-Jorn Y Peters; Gerjo Kok; Charles Abraham
Journal:  Addiction       Date:  2007-11-12       Impact factor: 6.526

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.